Welcome to the international HTA database

Showing [16733 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2019	Agency for Care Effectiveness (ACE)	Vedolizumab for treating ulcerative colitis and Crohn's disease
2019	National Institute for Health and Care Excellence (NICE)	Idelalisib for treating refractory follicular lymphoma. NICE technology appraisal guidance 604
2019	National Institute for Health and Care Excellence (NICE)	Curos for preventing infections when using needleless connectors. NICE medical technologies guidance 44
2019	NIHR Health Technology Assessment programme	Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with multiple sclerosis
2019	National Institute for Health and Care Excellence (NICE)	Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea. NICE technology appraisal guidance 605
2019	National Institute for Health and Care Excellence (NICE)	Lanadelumab for preventing recurrent attacks of hereditary angioedema. NICE technology appraisal guidance 606
2019	National Institute for Health and Care Excellence (NICE)	Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. NICE medical technologies guidance 41
2019	Agency for Care Effectiveness (ACE)	Febuxostat for treating chronic hyperuricaemia in adults with gout
2019	Agency for Healthcare Research and Quality (AHRQ)	Pharmacologic and nonpharmacologic therapies in adult patients with exacerbation of COPD
2019	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. NICE technology appraisal guidance 607
2019	National Institute for Health and Care Excellence (NICE)	Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers. NICE medical technologies guidance 40
2019	NIHR Health Technology Assessment programme	Peer-led walking programme to increase physical activity in inactive 60- to 70-year-olds: Walk with Me pilot RCT
2019	National Institute for Health and Care Excellence (NICE)	Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal). NICE technology appraisal guidance 608
2019	Agency for Care Effectiveness (ACE)	Ezetimibe and ezetimibe/simvastatin for treating primary hypercholesterolaemia
2019	National Institute for Health and Care Excellence (NICE)	Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal). NICE technology appraisal guidance 609
2019	Agency for Care Effectiveness (ACE)	Rifaximin for reducing recurrent episodes of overt hepatic encephalopathy
2019	National Institute for Health and Care Excellence (NICE)	Pentosan polysulfate sodium for treating bladder pain syndrome. NICE technology appraisal guidance 610
2019	Health Information and Quality Authority (HIQA)	Risk in pregnancy — systematic review of economic literature.
2019	NIHR Health Technology Assessment programme	Protocolised non-invasive compared with invasive weaning from mechanical ventilation for adults in intensive care: the Breathe RCT
2019	Agency for Care Effectiveness (ACE)	Botulinum toxin A for treating blepharospasm or hemifacial spasm
2019	National Institute for Health and Care Excellence (NICE)	Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. NICE technology appraisal guidance 611
2019	Health Information and Quality Authority (HIQA)	Budget impact analysis – stratification of clinical risk in pregnancy
2019	Agency for Care Effectiveness (ACE)	Oral COX-2 inhibitors for treating pain
2019	National Institute for Health and Care Excellence (NICE)	Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab. NICE technology appraisal guidance 612
2019	Health Information and Quality Authority (HIQA)	Systematic review of nutritional screening tools for adult patients in acute hospital settings. Nutrition screening and use of oral nutrition support for adults in the acute care setting
2019	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with influenza vaccination
2019	Agency for Care Effectiveness (ACE)	Ferric carboxymaltose for treating iron deficiency anaemia
2019	National Institute for Health and Care Excellence (NICE)	Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy. NICE technology appraisal guidance 613
2019	NIHR Health Technology Assessment programme	Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT
2019	Adelaide Health Technology Assessment (AHTA)	Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019	Agency for Care Effectiveness (ACE)	Botulinum toxin A for treating cervical dystonia
2019	National Institute for Health and Care Excellence (NICE)	Cannabidiol with clobazam for treating seizures associated with Dravet syndrome. NICE technology appraisal guidance 614
2019	NIHR Health Technology Assessment programme	Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT
2019	Adelaide Health Technology Assessment (AHTA)	Immunoglobulin for myasthenia gravis
2019	Agency for Care Effectiveness (ACE)	Botulinum toxin A for treating focal spasticity of the upper or lower limbs in children with cerebral palsy
2019	National Institute for Health and Care Excellence (NICE)	Cannabidiol with clobazam for treating seizures associated with Lennox-Gastaut syndrome. NICE technology appraisal guidance 615
2019	Adelaide Health Technology Assessment (AHTA)	Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019	Agency for Care Effectiveness (ACE)	Endothelin receptor antagonists for treating pulmonary arterial hypertension
2019	National Institute for Health and Care Excellence (NICE)	Cladribine for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 616
2019	NIHR Health Services and Delivery Research programme	Exploring the impact of patient experience data in acute NHS hospital trusts in England: using Actor-Network Theory to optimise organisational strategies and practices for improving patients' experiences of care
2019	Adelaide Health Technology Assessment (AHTA)	Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future
2019	Health Quality Ontario (HQO)	Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019	NIHR Health Technology Assessment programme	Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT
2019	NIHR Health Technology Assessment programme	Comprehensive geriatric assessment for frail older people in acute hospitals: the HoW-CGA mixed-methods study.
2019	NIHR Health Technology Assessment programme	A workplace-based intervention to increase levels of daily physical activity: the Travel to Work cluster RCT
2019	Agency for Healthcare Research and Quality (AHRQ)	Telehealth for acute and chronic care consultations
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Partial breast radiotherapy for patients with early breast cancer after breast conservation surgery
2019	NIHR Health Technology Assessment programme	Development and preliminary evaluation of an intervention package to support parents of excessively crying infants
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Volume-outcome relationships: pancreaticoduodenectomy (Whipple procedure). Final report
2019	NIHR Health Technology Assessment programme	Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT
2019	NIHR Public Health Research (PHR) programme	A multi-centre individual-randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH)
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Bedaquiline (assessment of an orphan drug after exceeding the turnover limit of €1 million)]
2019	Agency for Healthcare Research and Quality (AHRQ)	Treatment for acute pain: an evidence map
2019	NIHR Public Health Research (PHR) programme	Improving health, under community supervision, with the support of a Health Trainer: developing and evaluating a pilot randomised controlled trial
2019	NIHR Health Technology Assessment programme	Improving the mental health of children and young people with long term conditions: linked evidence syntheses
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive (AM-RL): Annex XII – Benefit assessment of medicinal products with new active ingredients according to section 35a SGB V brentuximab vedotin (new therapeutic indication: Hodgkin lymphoma, first line)]
2019	NIHR Health Technology Assessment programme	Clinical and demographic characteristics associated with delay in help-seeking behaviour in patients with Acute Coronary Syndrome
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Intravenous lidocaine for perioperative pain control
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Levalbuterol vs albuterol for hospitalized patients
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endoscopic sleeve gastroplasty (ESG) for the treatment of patients with Class I and Class II obesity with comorbidities who have failed first-line treatments
2019	National Institute for Health and Care Excellence (NICE)	Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. NICE diagnostics guidance 37
2019	NIHR Health Technology Assessment programme	Group cognitive behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations
2019	NIHR Health Technology Assessment programme	Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study
2019	NIHR Health Technology Assessment programme	Vitamin D supplementation to prevent acute respiratory infection: individual patient data meta-analysis of randomised controlled trials
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Triple-lumen peripherally-inserted central catheters
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Review of immunoglobulin use for chronic inflammatory demyelinating polyneuropathy
2019	National Institute for Health and Care Excellence (NICE)	Rapid tests for group A streptococcal infections in people with a sore throat. NICE diagnostics guidance 38
2019	NIHR Health Technology Assessment programme	Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Tip positioning of short-term central venous catheters
2019	National Institute for Health and Care Excellence (NICE)	Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis. NICE diagnostics guidance 36
2019	NIHR Health Technology Assessment programme	Fuelling health equity? The impact of the Winter Fuel Payment on the health of UK households
2019	NIHR Health Technology Assessment programme	Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic autopsy examination; feasibility study
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Timing of valve replacement for patients with infective endocarditis and intracranial embolism
2019	National Institute for Health and Care Excellence (NICE)	Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care. NICE diagnostics guidance 35
2019	NIHR Public Health Research (PHR) programme	How can interventions integrating health and academic education in schools help prevent substance misuse and violence, and reduce health inequalities among young people? Systematic review and evidence synthesis
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Participation in athletics by persons with thoracic aortic disease
2019	NIHR Health Technology Assessment programme	A behaviour change package to prevent hand dermatitis in nurses working in health care: the SCIN cluster RCT
2019	NIHR Health Services and Delivery Research programme	Evaluating the ten year impact of the Productive Ward at the clinical microsystem level in English acute trusts
2019	Health Quality Ontario (HQO)	Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019	Penn Medicine Center for Evidence-based Practice (CEP)	Postoperative chlorhexidine bathing to reduce surgical site infections among patients undergoing cardiac surgery
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Caplacizumab (New Therapeutic Indication: Acquired Thrombotic Thrombocytopenic Purpura, 12 to < 18 Years)]
2019	Adelaide Health Technology Assessment (AHTA)	Heritable Mutations associated with Familial Hypercholesterolaemia
2019	NIHR Public Health Research (PHR) programme	Mass media for public health messages
2019	NIHR Health Technology Assessment programme	E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Glycerol phenylbutyrate (New Therapeutic Indication: Urea cycle disorders in infants aged 0 to < 2 months)]
2019	European Network for Health Technology Assessment (EUnetHTA)	Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endoscopic sleeve gastroplasty (ESG) for the treatment of patients with Class I and II obesity who have failed first-line treatments
2019	European Network for Health Technology Assessment (EUnetHTA)	Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Ixazomib]
2019	NIHR Health Services and Delivery Research programme	Investigating the contribution of physician associates (PAs) to secondary care in England: a mixed methods study
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Paediatric deep brain stimulation
2019	Health Quality Ontario (HQO)	Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019	Technology Assessment at SickKids (TASK)	A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019	Health Technology Wales (HTW)	Procalcitonin point-of-care testing for initial assessment of suspected sepsis
2019	NIHR Health Technology Assessment programme	Platelet Rich Plasma (PRP) in Achilles Tendon Rupture (ATR) healing
2019	Technology Assessment at SickKids (TASK)	The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019	Health Technology Wales (HTW)	Fluorine- or gallium- prostate-specific membrane antigen (PSMA) positron emission tomography (PET) radiotracers in the investigation of recurrent prostate cancer
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Minimally invasive pancreaticoduodenectomy: the evidence
2019	NIHR Health Technology Assessment programme	Models Of Reablement Evaluation: a mixed methods evaluation of a complex intervention (The MORE project)
2019	Technology Assessment at SickKids (TASK)	A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis